Hostname: page-component-7dd5485656-c8zdz Total loading time: 0 Render date: 2025-10-23T23:16:28.204Z Has data issue: false hasContentIssue false
  • English
  • Français

The influence of propranolol on the exposure in vivo of agoraphobics

Published online by Cambridge University Press:  09 July 2009

Julian Hafner  and
Frank Milton
Julian Hafner*
Affiliation:
Kingston Hospital, Kingston-on-Thames, Surrey
Frank Milton
Affiliation:
Kingston Hospital, Kingston-on-Thames, Surrey
*
1Address for correspondence: Dr Julian Hafner, Clare House, St George's Hospital Medical School, Blackshaw Road, london SW17 0QT.
Get access Rights & Permissions [Opens in a new window]

Synopsis

This study examines the influence of 40 mg of propranolol on agoraphobics throughout 5-hour periods of exposure in vivo on 3 alternate days. Twenty-three patients were studied using a double-blind parallel design and 19 followed up for 3 months. The propranolol group spent significantly less time than the placebo group travelling alone in the month after treatment, and had improved significantly less on a measure of general symptoms at 3 months. The adverse influence of propranolol on treatment outcome appeared mainly due to a waning effect in the last hour of exposure. Attempts to measure coping with panics as an independent variable were largely unsuccessful.

Information

Type
Research Article
Information
Psychological Medicine , Volume 7 , Issue 3 , August 1977 , pp. 419 - 425
Copyright
Copyright © Cambridge University Press 1977

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Caine, T. M. & Hope, K. (1967). The Manual of the Hysteroid-Obsessoid Questionnaire. University of London Press.Google Scholar
Caine, T. M., Foulds, G. A. & Hope, K. (1967). The Manual of the Hostility and Direction of Hostility Questionnaire (HDHQ). University of London Press.Google Scholar
Crown, S. & Crisp, A. H. (1966). A short clinical diagnostic self-rating scale for psychoneurotic patients. British Journal of Psychiatry 112, 917–923.Google Scholar
Hafner, R. J. & Marks, I. M. (1976). Exposure in vivo of agoraphobics: contributions of diazepam, group exposure and anxiety evocation. Psychological Medicine 6, 71–88.CrossRefGoogle ScholarPubMed
Jefferson, J. W. (1974). Beta-adrenergic receptor blocking drugs in psychiatry. Archives of General Psychiatry 31, 681–691.Google Scholar
Marks, I. M. (1970). Agoraphobic syndrome. Archives of General Psychiatry 23, 538–553.Google Scholar
Marks, I. M. & Herst, E. R. (1970). A survey of 1200 agoraphobics in Britain. Social Psychiatry 5, 16–24.Google Scholar